Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy

Molecular Biology Reports

Volumn 40, Issue 6, 2013, Pages 3913-3923

  Tang, Li Qin ^a   Wang, Feng Ling ^a   Zhu, Ling Na ^a   Lv, Fei ^a   Liu, Sheng ^a   Zhang, Shan Tang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Berberine; cAMP; Cell proliferation; Diabetic nephropathy; G proteins

Indexed keywords

ADENYLATE CYCLASE; BERBERINE; COLLAGEN TYPE 4; CYCLIC AMP; ENALAPRIL; GLUCOSE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG ISOLATION; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; UPREGULATION;

ADENYLATE CYCLASE; ANIMALS; BERBERINE; BLOOD GLUCOSE; CELL PROLIFERATION; COLLAGEN TYPE IV; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FASTING; FIBRONECTINS; GTP-BINDING PROTEINS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MESANGIAL CELLS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS; RATTUS NORVEGICUS;

EID: 84877769735     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2468-0     Document Type: Article

References (60)

1. Guilbert JJ (2006) The World Health Report 2006: working together for health. Educ Health (Abingdon) 19:385-387
2. Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4:444-452
3. Kanwar YS, Sun L, Xie P et al (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395-423
4. Reutens AT, Atkins RC (2011) Epidemiology of diabetic nephropathy. Contrib Nephrol 170:1-7
5. Kobayashi T, Okada H, Inoue T et al (2006) Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy. Nephrol Dial Transplant 21:548-549
6. Guha M, Xu ZG, Tung D et al (2007) Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 21(12):3355-3368
7. Umezono T, Toyoda M, Kato M et al (2006) Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy. J Nephrol 19(6):751-757
8. Zhang Z, Kundu GC, Yuan CJ et al (1997) Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 276:1408-1412
9. Striker GE, Peten EP, Carome MA et al (1993) The kidney disease of diabetes mellitus (KDDM): a cell and molecular biology approach. Diabetes Metab Rev 9:37-56
10. Van Nieuwenhoven FA, Jensen LJ, Flyvbjerg A et al (2005) Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol Dial Transplant 20:6-10
11. Hoffman BB, Sharma K, Ziyadeh FN (1998) Potential role of TGF-βin diabetic nephropathy. Miner Electrolyte Metab 24:190-196
12. Goldschmeding R, Aten J, Ito Y et al (2000) Connective tissue growth factor: just another factor in renal fibrosis? Nephrol Dial Transplant 15:296-299
13. Boor P, Sebeková K, Ostendorf T et al (2007) Treatment targets in renal fibrosis. Nephrol Dial Transplant 22:3391-3407
14. Gupta S, Clarkson MR, Duggan J et al (2000) Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399
15. Wahab NA, Yevdokimova N, Weston BS et al (2001) Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 359:77-87
16. Yokoi H, Mukoyama M, Nagae T et al (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15:1430-1440
17. Giunti S, Barit D, Cooper ME (2006) Diabetic nephropathy: from mechanisms to rational therapies. Minerva Med 97:241-262
18. Gilman AG (1987) G-proteins: transducers of receptor generated signals. Annu Rev Biochem 56:615-649
19. Bourne HR, Sanders DA, McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125-132
20. Neer EJ, Heterotrimeric G (1995) Proteins: organizers of transmembrane signals. Cell 80:249-257
21. Jang IS, Juhnn YS (2001) Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein alpha, Q227L Gsalpha. Exp Mol Med 33(1):37-45
22. Salazar NC, Chen J, Rockman HA (2007) Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim Biophys Acta 1768:1006-1018
23. Yin J, Xing H, Ye J (2008) Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57:712-717
24. Yin J, Gao Z, Liu D et al (2008) Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294:E148-E156
25. Singh J, Kakkar P (2009) Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J Ethnopharmacol 123:22-26
26. Wang Y, Champbell T, Perry B (2011) Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. Metabolism 60(2):298-305
27. Liu WH, Hei ZQ, Nie H et al (2008) Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J (Engl) 121:706-712
28. Liu W, Liu P, Tao S et al (2008) Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Arch Biochem Biophys 475:128-134
29. Liu W, Tang F, Deng Y et al (2009) Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol Cell Biochem 325:99-105
30. Liu S, Tang LQ, Chen LM (2004) Study on extraction technology of berberine from Rhizoma coptidis by the method of orthogonal-test optimization. China Pharm 15:18-20
31. Xu SY, Bian RL, Chen X (2003) Experimental methods in pharmacology. People health publishing, Beijing, p 585
32. Zhou R, Guo JJ, Yin CM, et al (2003) Clinical observations of Xiaoke Wan in treatment of type 2 diabetic patients (Qi and Yin deficiency zheng). Zhongguo YaoWu Yu Lin Chuang 3:131-132 (Chinese)
33. Zhang HZ (1999) Clinical observation into Xiaoke Wan in the treatment of 86 cases of type 2 diabetic patients. Zhong Yi Yao Yan Jiu 15:19-21 (Chinese)
34. Itoh Y, Imamura S, Yamamoto K et al (2002) Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate. J Endocrinol 175(1):233-239
35. Fujiwara Y, Kitamura E, Ochi S et al (1991) Isotopic measurement of glomerular intracapillary volume as a quantitative index for mesangial cell contractility. Contrib Nephrol 95:12-21
36. Wolf G, Ziyadeh FN (1999) Molecular mechanism of diabetic renal hypertrophy. Kidney Int 56:393-405
37. Lu SS, Yu YL, Zhu HJ et al (2009) Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol 200:159-165
38. Schena FP (2005) Gesualdo L Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16(Suppl 1):S30-S33
39. Ichinose K, Kawasaki E, Eguchi K (2007) Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol 27:554-564
40. Liu Y (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidndy Int 69:213-217
41. Ruiz-Torres MP, Lopez-Ongil S, Griera M et al (2005) The accumulation of extracellular matrix in the kidney: consequences on cellular function. J Nephrol 18:334-340
42. Molitch ME, DeFronzo RA, Franz MJ et al (2004) American Diabetes Association. Nephropathy in diabetes. Diabetes Care 27:S79-S83
43. Chen S, Hong SW, Iglesias-de la Cruz MC et al (2001) The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Renal Fail 23:471-481
44. Ziyadeh FN, Sharma K, Ericksen M et al (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor beta. J Clin Invest 93:536-542
45. Murphy M, Docherty NG, Griffin B et al (2008) IHG-1 amplifies TGF-beta 1 signaling and is increased in renal fibrosis. J Am Soc Nephrol 19:1672-1680
46. Abdel WN, Mason RM (2004) Connective tissue growth factor and renal diseases: some answers, more questions. Curr Opin Nephrol Hypertens 13:53-58
47. Mason RM, Wahab NA (2003) Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14:1358-1373
48. Liu W, Zhang X, Liu P et al (2010) Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur J Pharmacol 638(1-3):150-155
49. Kurogi Y (2003) Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med Res Rev 23:15-31
50. Li X, Liu W, Wang Q (2009) Huang, et al. Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose. Mol Cell Endocrinol 307:157-162
51. Hashim S, Liu YY, Wang R et al (2002) Streptozotocin induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle. Mol Cell Biochem 240:57-65
52. Hashim S, Li Y, Nagakura A, Takeo S et al (2004) Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle. Cardiovasc Res 63:709-718
53. Zheng XL, Guo J, Wang HY, Malbon CC (1998) Expression of constitutively activated Gialpha2 in vivo ameliorates streptozotocin-induced diabetes. J Biol Chem 273:23649-23651
54. Li Y, Descorbeth M, Anand-Srivastava MB (2008) Role of oxidative stress in high glucose-induced decreased expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 294(6):H2845-H2854
55. Stryer L, Bourne HR (1986) G proteins: a family of signal transducers. Annu Rev Cell Biol 2:391-419
56. Spiegel AM (1987) Signal transduction by guanine nucleotide binding proteins. Mol Cell Endocrinol 49:1-16
57. Dumont JE, Jauniaux JC, Roger PP (1989) The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67-71
58. Li X, Zarinetchi F, Schrier RW et al (1995) Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells. Am J Physiol 269:C986-C991
59. Hashim S, Li Y, Anand-Srivastava MB (2006) G Protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia. Cell Biochem Biophys 44(1):51-64
60. Tang LQ, Lv F, Liu S et al (2011) Effect of berberine on expression of transforming growth factor-beta1 and type IV collagen proteins in mesangial cells of diabetic rats with nephropathy. Zhongguo Zhong Yao Za Zhi 36:3494-3497 (Chinese)